Potent bacterial toxins can be modified to be used in various ways to specifically target cancer cells. One such engineered toxin is approved for use to treat recurrent cutaneous T-cell lymphoma. Several other toxins are under investigation to treat patients with colon, breast, ovarian, lung cancer, and hematologic cancer.
Go to Previous Page
Go to Next Page